Exicure, Inc. (XCUR) saw its stock price rise significantly on Monday following the announcement of debt-for-equity exchange agreements. These agreements, detailed in a Form 8-K filing with the Securities and Exchange Commission, involve Exicure converting outstanding promissory notes into shares of its common stock.
The largest shareholder, DGP, holding approximately 35% of Exicure’s outstanding stock, agreed to exchange a $700,000 promissory note, including accrued interest, for 237,233 shares of Exicure’s common stock. Separately, an individual investor agreed to exchange a $300,000 promissory note, with accrued interest, for 101,991 shares of Exicure’s common stock.
These agreements represent a significant injection of capital for Exicure, potentially providing the company with much-needed financial resources to further its operations.
For investors interested in gaining exposure to Exicure, besides purchasing shares directly through a brokerage platform, there are other options. Investing in exchange-traded funds (ETFs) that track the healthcare sector can offer indirect exposure to Exicure, as these ETFs often hold shares in various companies within the sector. Similarly, allocating funds to a 401(k) strategy that targets mutual funds or instruments within the healthcare sector can provide exposure to Exicure and other related companies.
The announcement of these debt-for-equity agreements has significantly boosted Exicure’s stock price, demonstrating the market’s positive response to the company’s efforts to strengthen its financial position. This move could potentially position Exicure for future growth and development within the healthcare industry.
